FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/02/031542 [Registered on: 25/02/2021] Trial Registered Prospectively
Last Modified On: 30/05/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Siddha 
Study Design  Single Arm Study 
Public Title of Study   A Clinical study on cervical spondylosis using thengaai thuruval ottradam (external therapy) 
Scientific Title of Study   A clinical study to evaluate the therapeutic efficacy of THENGAAI THURUVAL OTTRADAM [External Therapy] in the management of CEGANA VATHAM [CERVICAL SPONDYLOSIS] 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr M F Muhammad Hafeez 
Designation  PG scholar 
Affiliation  Government Siddha medical college and hospital 
Address  PG Pura Maruthuvam OP No 4 Government Siddha medical college and hospital Palayamkottai Tirunelveli
PG Pura Maruthuvam OP No 4 Government Siddha medical college and hospital Palayamkottai Tirunelveli TamilNadu
Tirunelveli
TAMIL NADU
627002
India 
Phone  9443882877  
Fax    
Email  hafeezmf75@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr M Ahamed Mohideen MDs 
Designation  Associate Professor 
Affiliation  Government Siddha medical college and hospital 
Address  PG Pura Maruthuvam OP No 4 Government Siddha medical college and hospital Palayamkottai Tirunelveli
PG Pura Maruthuvam OP No 4 Government Siddha medical college and hospital Palayamkottai Tirunelveli
Tirunelveli
TAMIL NADU
627002
India 
Phone  9442542282  
Fax    
Email  dr.ahmed63@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr M Ahamed Mohideen MDs 
Designation  Associate Professor 
Affiliation  Government Siddha medical college and hospital 
Address  PG Pura Maruthuvam OP No 4 Government Siddha medical college and hospital Palayamkottai Tirunelveli
PG Pura Maruthuvam OP No 4 Government Siddha medical college and hospital Palayamkottai Tirunelveli

TAMIL NADU
627002
India 
Phone  9442542282  
Fax    
Email  dr.ahmed63@gmail.com  
 
Source of Monetary or Material Support  
OPD and IPD facilities and Central Library of Government Siddha medical college and hospital 
 
Primary Sponsor  
Name  Government Siddha medical college and hospital 
Address  PG Pura Maruthuvam OP No 4 Government Siddha medical college and hospital Palayamkottai Tirunelveli TamilNadu 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr M F Muhammad Hafeez  Government Siddha medical college and hospital  Government Siddha medical college and hospital Palayamkottai
Tirunelveli
TAMIL NADU 
9443882877

hafeezmf75@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M478||Other spondylosis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Not applicable  Not applicable 
Intervention  THENGAAI THURUVAL OTTRADAM (EXTERNAL THERAPY)  ottradam will be given once a day for 48 days 
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Neck pain
Radiating pain to upper limbs
With or without numbness in the upper limbs
Giddiness and neck stiffness
Patients who are willing to give blood samples for laboratory investigation
Patients who are willing to take X-ray before and after treatment
Willing for admission in IPD for 48 days or willing to attend OPD regularly
Patients who are willing to participate in this study with knowledge of potential risks and who are willing to sign the informed consent
 
 
ExclusionCriteria 
Details  Cardiac disease
Tuberculosis in spine
Spina bifida
Use of narcotic drugs
Pregnant women and lactating mother
Trauma, Fracture, Ligament injury
Patient with any other serious illness.
Benign and malignant neoplasm
Congenital spinal anomalies
Dermatological issues
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Improvement in lab parameters and relief of clinical symptoms   48 days  
 
Secondary Outcome  
Outcome  TimePoints 
Reduction inrestriction of movements
To evaluate effect of ottradam
To study the siddha principles before and after treatment
 
48 days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "40"
Final Enrollment numbers achieved (India)="40" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/03/2021 
Date of Study Completion (India) 28/04/2022 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
The study is A Clinical study to evaluate the therapeutic efficacy of THENGAAI THURUVAL OTTRADAM in the management of cegana vatham (cervical spondylosis). The trial will be given externally as a ottradam therapy for 48 days in 40 patients. The trial period of 12 months will be carrying out in government Siddha medical college and hospital, Palayamkottai Tirunelveli TamilNadu. Primary outcome is improvement in lab parameters and relief of clinical symptoms. The secondary outcome is reduction in restriction of movements and evaluate the effect of ottradam. In case of any adverse event (AE) is noticed and it will be referred to pharmacovigilance department of SCRI. Further management of patient will be given in OPD facility. 
Close